Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Gastroenterology
•
General Gastroenterology
What recommendations do you provide to advance an inpatient’s oral tolerance in the setting of an unspecified vomiting disorder?
Related Questions
Under what circumstances would you recommend early fecal microbiota transplantation over antibiotic treatment or bezlotoxumab in a patient with recurrent C. difficile infection?
What inpatient diagnostic workup do you pursue in a patient with an unspecified vomiting disorder who cannot be discharged due to poor PO tolerance?
Do you accelerate your withdrawal time with the utilization of add-on devices to the colonoscope (such as EndoCuff) that enhance mucosal inspection and polyp detection?
Which colonic polyp or mass-like lesions do you refer to an advanced endoscopist?
What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What factors guide your choice of hot snare polypectomy vs cold snare polypectomy for non-pedunculated colonic polyps between 10-20 mm in size and those greater than 20 mm in size?
Has your institution and/or antimicrobial stewardship program incorporated a selective antibiotic approach to treatment of left-sided uncomplicated diverticulitis in immunocompetent patients?
How do you use gut microbiome or gut microbiota analysis in your clinical practice, if at all?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
